Navigation Links
Probiotic good bugs may control gut infections
Date:9/4/2007

Probiotics, the friendly bacteria beloved of yoghurt advertisers, may be an effective substitute for growth promoting antibiotics in pigs, giving us safer pork products, according to scientists speaking today (Wednesday 5 September 2007) at the Society for General Microbiologys 161st Meeting at the University of Edinburgh, UK, which runs from 3-6 September 2007.

Scientists from the UKs Veterinary Laboratories Agency in Weybridge, Surrey have shown that probiotics the good bacteria taken by millions of people worldwide can reduce the disease-causing Salmonella bacteria which infect people and pigs.

Salmonella is responsible for thousands of food poisoning cases each year with many of the cases originating from infected pork products. Recently the European Union banned the use of antibiotics in animal feed. Antibiotics were being regularly used as growth promoters to make pigs put on weight and protect them from diseases, says James Collins from the Veterinary Laboratories Agency.

The EU ban is part of the effort to reduce the emergence of new antibiotic resistant bacteria, particularly as many disease-causing and antibiotic-resistant bacteria such as MRSA and clostridia are now so common, says James Collins.

The scientists have also managed to advance the use of alternatives in animal testing by developing a technique based on NASA space technology, which allowed them to grow small pieces of pig gut in a 3-dimensional matrix which mimics the natural environment in a pigs gut.

The 3D model specifically allows us to test the potential health benefits of probiotics as viable alternatives to growth promoters in pigs, says James Collins. This model is an essential first step as an alternative to the use of animals in scientific research, and means that we did not need to do the work in live pigs.

The work by the Surrey team will contribute to reducing the number of pigs carrying Salmonella, and so cut its general spread in the environment. This in turn is expected to reduce the number of Salmonella related food poisoning cases reported every year.

The scientists have not yet discovered exactly how the probiotics work, but they hope that their new model will uncover the mechanism behind the way probiotics reduce pathogens in the gut and confer other health benefits.


'/>"/>
Contact: Lucy Goodchild
l.goodchild@sgm.ac.uk
44-011-898-81843
Society for General Microbiology
Source:Eurekalert

Related biology technology :

1. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
2. Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in Mammalian Cells
3. Human t-PA Control Primer Set
4. Rapid PCR* Using Active Tube Temperature Control On Thermos PCR Machines
5. Housekeeping Genes: Universal Positive Controls in siRNA Knockdown Experiments
6. Quality control of antibodies using the 2100 bioanalyzer and the Protein 200 Plus assay
7. Using the Agilent 2100 bioanalyzer for quality control of protein samples prior to MS-analysis
8. Advancing the quality control methodology to assess isolated total RNA and generated fragmented cRNA
9. Control Your siRNA Research
10. Designing Controls for siRNA Experiments
11. RNAi: The Controls You Need
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)...  Today, the Fisher Center for Alzheimer,s Research Foundation ... study that could lead to the development of effective ... This groundbreaking research was conducted by the Fisher Center ... Dr. Paul Greengard , in the quest to ... Center scientists have linked a mutation that protects elderly ...
(Date:1/23/2017)... 23, 2017   Enteris BioPharma, Inc. , announced ... Sanofi to leverage Enteris, proprietary and patented ... develop an oral formulation of one of Sanofi,s preclinical ... Chief Executive Officer and Executive Chairman of Enteris BioPharma, ... the tremendous value our Peptelligence platform program offers in ...
(Date:1/23/2017)... CARLOS, Calif. , Jan. 23, 2017 /PRNewswire/ ... developing innovative treatments for neurodegenerative diseases and other ... has joined the company as Chief Medical Officer. ... translational and clinical development activities at Alkahest and ... Dr. Jackson most recently served as Executive Director ...
(Date:1/21/2017)... ... January 20, 2017 , ... Nipro Corporation (Osaka, Japan) and Transonic Systems ... Nipro will receive exclusive marketing and sales rights for all non-OEM Transonic products in ... patients in Japan, the new Nipro - Transonic JV is a natural next step ...
Breaking Biology Technology:
(Date:12/22/2016)... YORK , December 22, 2016 ... provider of secure solutions for the e-Government, Public Safety, HealthCare, and ... subsidiary of SuperCom, has been selected to implement and deploy a ... in Northern California , further expanding its presence ... ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
(Date:12/16/2016)... -- The global wearable medical device market, in terms of value, ... 5.31 billion in 2016, at a CAGR of 18.0% during the ... ... medical devices, launch of a growing number of smartphone-based healthcare apps ... providers, and increasing focus on physical fitness. Furthermore, ...
Breaking Biology News(10 mins):